Design
Review
Authors
Loading...
Caveolin modulation should not yet change practice; leaves open targeted therapies for age-associated heart failure and pulmonary hypertension.
Key points are not available for this paper at this time.
Fridolfsson et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: